Glutamine and cancer: cell biology, physiology, and clinical opportunities.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Clinical Investigation

• Publication date

  2013-09-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI69600PMID 23999442PMCID PMC3754270
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Control of nutrient stress-induced metabolic reprogramming by PKCζ in tumorigenesis.

  2013cited by this paper
• (4S)-4-(3-18F-Fluoropropyl)-l-Glutamate for Imaging of xC¯ Transporter Activity in Hepatocellular Carcinoma Using PET: Preclinical and Exploratory Clinical Studies

  2013cited by this paper
• Glutamine supports pancreatic cancer growth through a Kras-regulated metabolic pathway

  2013cited by this paper
• Glutaminase isoenzymes as key regulators in metabolic and oxidative stress against cancer.

  2013influential reference
• Glutamine deprivation enhances antitumor activity of 3-bromopyruvate through the stabilization of monocarboxylate transporter-1.

  2012cited by this paper
• Selection of Metastatic Breast Cancer Cells Based on Adaptability of Their Metabolic State

  2012cited by this paper
• Deprive to kill

  2012cited by this paper
• Links between metabolism and cancer.

  2012cited by this paper
• MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors

  2012cited by this paper
• How cancer metabolism is tuned for proliferation and vulnerable to disruption

  2012cited by this paper
• Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence

  2012cited by this paper
• Genetically-defined metabolic reprogramming in cancer.

  2012cited by this paper
• Comparative Evaluation of 18F-Labeled Glutamic Acid and Glutamine as Tumor Metabolic Imaging Agents

  2012cited by this paper
• Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo.

  2012influential reference
• Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells.

  2012cited by this paper
• Analysis of glutamine dependency in non-small cell lung cancer

  2012cited by this paper
• ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivation.

  2012influential reference
• SLC1A5 Mediates Glutamine Transport Required for Lung Cancer Cell Growth and Survival

  2012cited by this paper
• Metabolism of [U‐13C]glucose in human brain tumors in vivo

  2012cited by this paper
• Exploratory Clinical Trial of (4S)-4-(3-[18F]fluoropropyl)-l-glutamate for Imaging xC− Transporter Using Positron Emission Tomography in Patients with Non–Small Cell Lung or Breast Cancer

  2012cited by this paper
• The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type.

  2012cited by this paper
• Specific PET Imaging of xC− Transporter Activity Using a 18F-Labeled Glutamate Derivative Reveals a Dominant Pathway in Tumor Metabolism

  2011cited by this paper
• Comparative Metabolic Flux Profiling of Melanoma Cell Lines

  2011cited by this paper
• Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia

  2011cited by this paper
• Reductive carboxylation supports growth in tumor cells with defective mitochondria

  2011cited by this paper
• Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability

  2011cited by this paper
• Role of Glutamine in Cancer: Therapeutic and Imaging Implications

  2011cited by this paper
• Pyruvate carboxylase is required for glutamine-independent growth of tumor cells

  2011cited by this paper
• Exchange facilitated indirect detection of hyperpolarized 15ND2-amido-glutamine.

  2011cited by this paper
• Glutamine Synthetase Is a Genetic Determinant of Cell Type–Specific Glutamine Independence in Breast Epithelia

  2011cited by this paper
• Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research.

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• PET Imaging of Glutaminolysis in Tumors by 18F-(2S,4R)4-Fluoroglutamine

  2011cited by this paper
• Recent advances in neuroblastoma.

  2010cited by this paper
• The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism.

  2010cited by this paper
• Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species

  2010cited by this paper
• Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply.

  2010cited by this paper
• Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer

  2010cited by this paper
• Targeting mitochondrial glutaminase activity inhibits oncogenic transformation.

  2010cited by this paper
• Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling.

  2009cited by this paper
• c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism

  2009cited by this paper
• Is glutamine a conditionally essential amino acid?

  2009cited by this paper
• Bidirectional transport of amino acids regulates mTOR and autophagy.

  2009cited by this paper
• Glutamine-dependent anapleurosis dictates glucose uptake and cell growth by regulating MondoA transcriptional activity

  2009cited by this paper
• Faculty Opinions recommendation of c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism.

  2009influential reference
• Targeting aspartate aminotransferase in breast cancer

  2008cited by this paper
• Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction

  2008influential reference
• 13C MR spectroscopy measurements of glutaminase activity in human hepatocellular carcinoma cells using hyperpolarized 13C‐labeled glutamine

  2008cited by this paper
• Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis

  2007cited by this paper
• Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells

  2007cited by this paper
• Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES).

  2007cited by this paper
• Glutamine utilization by the small intestine.

  2006cited by this paper
• Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children's Oncology Group (CCG 09709).

  2006cited by this paper
• Green Tea Polyphenols Modulate Insulin Secretion by Inhibiting Glutamate Dehydrogenase*

  2006influential reference
• L-Glutamine ameliorates acetaldehyde-induced increase in paracellular permeability in Caco-2 cell monolayer.

  2004cited by this paper
• Glutamine metabolism: Role in acid‐base balance *

  2004cited by this paper
• Cell adhesion and signalling by cadherins and Ig-CAMs in cancer

  2004cited by this paper
• Pulmonary glutamine production: effects of sepsis and pulmonary infiltrates

  2003cited by this paper
• Regional muscle and adipose tissue amino acid metabolism in lean and obese women.

  2002cited by this paper
• Inhibition of glutaminase expression by antisense mRNA decreases growth and tumourigenicity of tumour cells.

  2000cited by this paper
• Investigation

  2000cited by this paper
• Role of glutamine in human carbohydrate metabolism in kidney and other tissues.

  1999cited by this paper
• Glutamine synthetase expression in rat lung is regulated by protein stability.

  1998cited by this paper
• Glutamine synthetase expression in rat lung is regulated by protein stability.

  1998cited by this paper
• A causal role for E-cadherin in the transition from adenoma to carcinoma

  1998cited by this paper
• Inhibition of pulmonary microvascular endothelial glutamine transport by glucocorticoids and endotoxin.

  1995cited by this paper
• Renal oxygen consumption, thermogenesis, and amino acid utilization during i.v. infusion of amino acids in man.

  1994cited by this paper
• Na(+)-dependent glutamine transport in the liver of tumour-bearing rats.

  1993cited by this paper
• Influence of Progressive Tumor Growth on Glutamine Metabolism in Skeletal Muscle and Kidney

  1993influential reference
• Relevance of glutamine metabolism to tumor cell growth

  1992cited by this paper
• Splanchnic, renal, and muscle clearance of alanylglutamine in man and organ fluxes of alanine and glutamine when infused in free and peptide forms.

  1990cited by this paper
• Role of the lungs in maintaining amino acid homeostasis.

  1990cited by this paper
• Metabolism and action of amino acid analog anti-cancer agents.

  1990cited by this paper
• Gut glutamine metabolism.

  1990cited by this paper
• Lung glutamine metabolism.

  1990cited by this paper
• Accelerated lung amino acid release in hyperdynamic septic surgical patients.

  1990cited by this paper
• Rates of utilization of glucose, glutamine and oleate and formation of end-products by mouse peritoneal macrophages in culture.

  1989cited by this paper
• Interorgan glutamine metabolism in the tumor-bearing rat.

  1988cited by this paper
• Glutamine and glucose metabolism in human peripheral lymphocytes.

  1988cited by this paper
• Glutamine metabolism in lymphocytes of the rat.

  1983cited by this paper
• Leucine degradation and release of glutamine and alanine by adipose tissue.

  1980cited by this paper
• Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells.

  1979cited by this paper
• Intracellular free amino acid concentration in human muscle tissue.

  1974cited by this paper
• Evidence of inter-organ amino-acid transport by blood cells in humans.

  1973cited by this paper

• Sweet optimization: glucose-vitrified samples for hyperpolarizing glutamine in biological studies.

  2026cites this paper
• Unravelling the pathogenesis and therapeutic approaches of pancreatic ductal adenocarcinoma.

  2026cites this paper
• Establishment of an amino acid metabolism related signature for prognostic and therapeutic sensitivity prediction in breast cancer by machine learning

  2026cites this paper
• Self-Transforming Bioadhesive Patch with Topological and Ionic Crosslinking for Adaptive Mucoadhesion and Enhanced Wound Healing.

  2026cites this paper
• Glycolysis-stratified coordination of fatty acid and glutamine metabolism in pancreatic ductal adenocarcinoma

  2026cites this paper
• Post-translational modifications in ferroptosis: mechanisms and therapeutic potential

  2026cites this paper
• ¹H-NMR serum metabolomic profiling from clinical routine identifies signatures of progressive melanoma metastasis

  2026cites this paper
• miR-4652-3p suppresses glutamine metabolism induced by the inflammatory microenvironment in non-small cell lung cancer by regulating MYC/SLC1A5.

  2026cites this paper
• From Structure to Vulnerability: Mitochondrial Supercomplexes in Cancer Cells

  2026cites this paper
• Obesity as a Systems-Level Driver of Cancer: Mechanisms and Nutritional Reprogramming.

  2025cites this paper
• Metabolic signatures in gastroenteropancreatic neuroendocrine neoplasms: unraveling diagnostic and prognostic insights

  2025cites this paper
• Immune and metabolic remodeling following bariatric surgery: Implications for targeted immunotherapy (Review)

  2025cites this paper
• GCDH Promotes Breast Cancer Glutaminolysis Reprogramming by Inducing GLS1 Expression Through Histone Crotonylation at Its Promoter Region

  2025cites this paper
• Arginine: at the crossroads of nitrogen metabolism

  2025cites this paper
• Prognostic and Therapeutic Potential of Nicotinamide N-Methyltransferase and Hypoxia Inducible Lipid Droplet Associated in Clear Cell Renal Cell Carcinoma

  2025cites this paper
• Amino acids metabolism: a potential target for cancer treatment

  2025cites this paper
• Tailoring imaging probes for defining glioma invasive margins: Tracing the molecular footprints of cancer cells.

  2025cites this paper
• Overview of glutamine metabolism in stromal components of the tumor microenvironment and potential anti-tumor therapies

  2025cites this paper
• SLC4A11 is a targetable marker correlated with therapeutic responses in ovarian cancer

  2025cites this paper
• Spatial isotope deep tracing deciphers inter-tissue metabolic crosstalk

  2025cites this paper
• Molecular subtypes based on the expression of glutamine metabolism-related genes predict prognosis, tumor microenvironment, and drug therapy response of colon adenocarcinoma.

  2025cites this paper
• Molecular network of metabolic reprogramming and precision diagnosis and treatment of hepatocellular carcinoma

  2025cites this paper
• Cat Eye Syndrome Chromosome Region Candidate 2 (CECR2) in chromatin remodeling and cancer: A review.

  2025cites this paper
• Metabolic Reprogramming in Urological Tumors: New Perspectives from Tumor Metabolic Phenotypes to Therapeutic Targets

  2025cites this paper
• Redox–Amino Acid Metabolic Crosstalk in Ovarian Cancer Stem Cells: Integrating Metabolic Reprogramming, Signaling, and the Tumor Microenvironment

  2025cites this paper
• Leveraging Cancer Metabolism to Translate into Effective Therapeutics.

  2025cites this paper
• Folate-targeted nanoparticles for glutamine metabolism inhibition enhance anti-tumor immunity and suppress tumor growth in ovarian cancer.

  2025cites this paper
• Exosomes loaded with metabolites: Roles in crosstalk between tumor cells and their microenvironment.

  2025cites this paper
• Metabolic reprogramming and immunological changes in the microenvironment of esophageal cancer: future directions and prospects

  2025cites this paper
• Moxibustion Alleviates Inflammation via SIRT5-mediated Post-translational Modification and Macrophage Polarization

  2025cites this paper
• Glutamine: a new strategy for targeted metabolic therapy in the tumor microenvironment

  2025cites this paper
• Glutamine Metabolism: Molecular Regulation, Biological Functions, and Diseases

  2025cites this paper
• Yuanhuacine suppresses head and neck cancer growth by promoting ASCT2 degradation and inhibiting glutamine uptake

  2025cites this paper
• Metabolic Pathway Analysis of Tumors Using Stable Isotopes.

  2025cites this paper
• Eliminating Assay Background of a Low-Cost, Colorimetric Glutamine Biosensor by Engineering an Alternative Formulation of Cell-Free Protein Synthesis

  2025cites this paper
• Dual asparagine-depriving nanoparticles against solid tumors

  2025cites this paper
• Ultrafast J-resolved magnetic resonance spectroscopic imaging for high-resolution metabolic brain imaging

  2025cites this paper
• Dexmedetomidine promotes colorectal cancer progression mediated by gamma-aminobutyric acid signaling

  2025cites this paper
• Integrative Multi-Omics Profiling of Rhabdomyosarcoma Subtypes Reveals Distinct Molecular Pathways and Biomarker Signatures

  2025cites this paper
• Characteristic metabolite profile of 10 colorectal cancer-related bacteria

  2025cites this paper
• Exploring solute carriers as biomarkers and therapeutic targets in esophageal squamous cell carcinoma

  2025cites this paper
• Mitochondria and tumorigenesis: Molecular basis and therapeutic implications

  2025cites this paper
• Development of a theranostic tri-nuclear gadolinium(III) complex based on apoferritin for multitarget therapy of orthotopic glioma

  2025cites this paper
• Modulation of bioenergetic metabolism by PDIA3 inhibition prevents breast cancer cell adhesion to endothelial cells.

  2025cites this paper
• Suppressing glutamine metabolism in the pancreatic cancer microenvironment can enhance the anti-tumor effect of CD8 T cells and promote the efficacy of immunotherapy

  2025cites this paper
• Optimized fungal chitosan-based pegasparaginase immobilization for intravenous delivery to enhance treatment of acute lymphoblastic leukaemia

  2025cites this paper
• Results of the phase I/II study and preliminary B cell gene signature of combined inhibition of glutamine metabolism and EGFR in colorectal cancer.

  2025cites this paper
• L-Glutamine Supplementation Improves the In Vitro Qualitative Parameters of Cryopreserved Qinchuan Bull Sperm

  2025cites this paper
• GLP-1 signaling in tumor metabolism and immunity: mechanisms and strategies.

  2025cites this paper
• One-Shot Rational Design of Covalent Drugs with CovalentLab

  2025cites this paper
• A pancancer analysis reveals the oncogenic role of glutaminase 1 (GLS1) in tumor metabolism and immune evasion: a bioinformatics analysis

  2025cites this paper
• FOXA2 promotes glutamine metabolism to facilitate the malignant development of bladder cancer by transcriptionally increasing GLS1 expression.

  2025cites this paper
• miR-199a-5p inhibits malignant progression and enhances cisplatin sensitivity of nasopharyngeal carcinoma by targeting SLC1A5

  2025cites this paper
• SIRT6–GLUL axis: rewiring nitrogen metabolism in intrahepatic cholangiocarcinoma

  2025cites this paper
• The suppressive role of GLS in radiosensitivity and irradiation-induced immune response in LUAD: integrating bioinformatics and experimental insights

  2025cites this paper
• The Moonlighting Function of GLS2 Promotes Immune Evasion of Pancreatic Ductal Adenocarcinoma by TTLL1-mediated YAP1 Glutamylation.

  2025cites this paper
• Alpha-ketoglutarate promotes random-pattern skin flap survival by enhancing angiogenesis via PI3K/Akt/HIF-1α signaling pathway

  2025cites this paper
• Mitochondrial glutamine import sustains electron transport chain integrity independently of glutaminolysis in cancer.

  2025cites this paper
• MetaboLINK is a novel algorithm for unveiling cell-specific metabolic pathways in longitudinal datasets

  2025cites this paper
• Infectious Spleen and Kidney Necrosis Virus ORF093R and ORF102R Regulate Glutamate Metabolic Reprogramming to Support Virus Proliferation by Interacting with c-Myc

  2025cites this paper
• Micropeptide hSPAR regulates glutamine levels and suppresses mammary tumor growth via a TRIM21-P27KIP1-mTOR axis

  2025cites this paper
• Carbohydrate polymer-based nanoparticles in curcumin delivery for cancer therapy: A review.

  2025cites this paper
• The solid tumor microenvironment and related targeting strategies: a concise review

  2025cites this paper
• Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation

  2025cites this paper
• Combined inhibition of de novo glutathione and nucleotide biosynthesis is synthetically lethal in glioblastoma

  2025cites this paper
• 细胞转录组学和代谢组学整合策略表征突变影响谷氨酰胺合成酶酶活的关键代谢通路

  2025cites this paper
• Metabolic Supremacy Fuels Tumor Aggressiveness in Renal Cancer

  2025cites this paper
• The m6A reader IGF2BP2 promotes pancreatic cancer progression through the m6A-SLC1A5-mTORC1 axis

  2025cites this paper
• Mutational insights into human kynurenine aminotransferase 1: modulation of transamination and β-elimination activities across diverse substrates

  2025cites this paper
• Glutamine’s double-edged sword: fueling tumor growth and offering therapeutic hope

  2025cites this paper
• The Role of SLC7A11 in Arsenite-Induced Oncogenic Phenotypes of Human Bronchial Epithelial Cells: A Metabolic Perspective.

  2025cites this paper
• Extracellular Vesicles in Cancer Immunotherapy: Therapeutic, Challenges and Clinical Progress

  2025cites this paper
• A phase I/II study of the safety and efficacy of telaglenastat (CB-839) in combination with nivolumab in patients with metastatic melanoma, renal cell carcinoma, and non-small-cell lung cancer

  2025cites this paper
• Glutamine modulates stress granule formation in cancer cells through core RNA-binding proteins

  2025cites this paper
• Allosteric inhibitors for the treatment of cancers (2021-): A review from medicinal chemistry perspectives

  2025cites this paper
• The RNA demethylase FTO promotes glutamine metabolism in clear cell renal cell carcinoma through the regulation of SLC1A5

  2025cites this paper
• Enzymes define pathways and metabolic relationships

  2025cites this paper
• Glutamic Acid Functionalized Bis-Cyano-di-Stilbene Bolaamphiphile: Synthesis, Aggregation Induced Emission Properties, Molecular Interactions Study with Potential as Anticancer Agents

  2025cites this paper
• Effects of SLC6A8 mutation-induced creatine deficiency on cellular function in fibroblasts

  2025cites this paper
• Altered fatty acid oxidation via CPT1A promotes epithelial‐to‐mesenchymal transition in ovarian cancer

  2025cites this paper
• Emerging regulated cell death mechanisms in bone remodeling: decoding ferroptosis, cuproptosis, disulfidptosis, and PANoptosis as therapeutic targets for skeletal disorders

  2025cites this paper
• Antitumor efficacy achieved by targeting PEGylated nanomedicines to netrin-1 in the extracellular matrix or EphA2 on the cancer cell membrane.

  2025cites this paper
• Imaging the uptake and metabolism of glutamine in prostate tumor models using CEST MRI

  2025cites this paper
• Delivery-Graded Programmable Micelles Achieve Enhanced Tumor Starvation through Combined Glutamine Deprivation and Angiogenesis Inhibition

  2025cites this paper
• Neurotransmitters: an emerging target for therapeutic resistance to tumor immune checkpoint inhibitors

  2025cites this paper
• Glutaminase inhibition ameliorates cancer-associated fibroblast lipid support of pancreatic cancer cell growth

  2025cites this paper
• Succinylation – encoded metabolic codes: cracking the molecular logic of cellular adaptation

  2025cites this paper
• LINC00114 promotes colorectal cancer metastasis by targeting HNRNPA1 to regulate glutamine metabolism reprogramming and angiogenesis

  2025cites this paper
• Integrating Metabolic Modulation and Nanomedicine for Cancer Immunotherapy

  2025cites this paper
• The Roles, Mechanisms, and Clinical Significance of Long Non-coding RNA MSC-AS1 in Cancer.

  2025cites this paper
• The role of fatty acid oxidation in metabolic crosstalk between tumor cells and associated factors in the microenvironment.

  2025cites this paper
• Tumour microbiota activities associated with local recurrence in ER + PR + breast cancer

  2025cites this paper
• Glutamine modulates cellular size by regulating Wee1 expression

  2025cites this paper
• Arginine Competition in Tumor Microenvironment: A Potential Target for Cancer Therapy

  2025cites this paper
• GLS2-mediated YAP1 Glutamylation Facilitates Immune Evasion in Pancreatic Ductal Adenocarcinoma.

  2025cites this paper
• Ammonium metabolism rewiring in the prostate cancer microenvironment: Mechanisms and clinical prospects

  2025cites this paper
• Clinical significance of the tumor microenvironment on immune tolerance in gastric cancer

  2025cites this paper
• Inhibition of glutamine synthetase enhances hepatocellular carcinoma radiosensitivity through ROS-induced excessive mitophagy

  2025cites this paper
• Targeting Ferroptosis in Sensorineural Hearing Loss: A Mechanistic Review of Therapeutic Opportunities

  2025cites this paper
• Targeting amino acid metabolism to inhibit gastric cancer progression and promote anti-tumor immunity: a review

  2025cites this paper